Major advances in medicine that lead to measurable improvements in public health require focused intellectual and financial commitment. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Quantum Grants Program to make a profound (quantum) impact on the prevention, diagnosis, or treatment of a major disease or national public health problem through the development and implementation of biomedical technologies within 10 to 12 years. This program challenges the research community to propose projects that have a highly focused, collaborative, interdisciplinary, milestone-driven approach targeted at solving a major medical or public health challenge through technological innovation.
Examples of Quantum grants include computer-designed cardiovascular implants that do not require anticoagulation therapy, a microchip to capture circulating tumor cells for very early cancer detection, self-administered influenza vaccines that could be sent through the mail, an implantable and self-regulating artificial kidney, a bioengineered replacement unit of neural stem cells and vasculature for stroke recovery, and imaging technology for more rapid and personalized treatment of acute ischemic strokes.
Applicants planning to submit a Quantum Grant application with direct costs of $500,000 or more are reminded that they must submit a white paper and budget using the templates below, and seek written agreement from the NIBIB staff at least 6 weeks prior to the application receipt date. Applicants are encouraged to contact the NIBIB staff well in advance of the 6 week deadline to discuss their planned application.
NIBIB Supported Projects
Influenza Vaccination Using a Microneedle Patch
Georgia Institute of Technology
Optimizing Cardiovascular Device Thromboresistance for Eliminating Anticoagulants
State University New York Stony Brook
Building an Implantable Artificial Kidney
University of California, San Francisco
One-Stop Shop Imaging for Acute Ischemic Stroke Treatment
University of Wisconsin
Point-of-Care Microfluidics for Early Detection of Cancer
Mehmet Toner and Daniel Haber
Massachusetts General Hospital